ABEONA THERAPEUTICS INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ABEONA THERAPEUTICS INC. (ABEO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 98.44 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-31
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 104.99M shares, a 13.05% increase year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 97.99M shares, a 5.69% increase year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 96.51M shares, a 4.11% increase year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 94.23M shares, a 2.03% increase year-over-year.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 98.44M shares, a 6.24% increase from fiscal 2020.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 92.66M shares, a 84.02% increase from fiscal 2019.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 50.35M shares, a 5.95% increase from fiscal 2018.
- ABEONA THERAPEUTICS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 47.53M shares, a 14.15% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | 104.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 101.49M shares derived: average of 2 quarters · filed 2022-03-31 | 99.83M shares derived: average of 3 quarters · filed 2022-03-31 | 98.44M shares 10-K · filed 2022-03-31 | |||
| 2021-09-30 | 97.99M shares 10-Q · filed 2021-11-15 | 97.25M shares derived: average of 2 quarters · filed 2021-11-15 | 96.26M shares 10-Q · filed 2021-11-15 | 95.40M shares derived: average of 4 quarters · filed 2022-03-31 | |||
| 2021-06-30 | 96.51M shares 10-Q · filed 2021-07-28 | 95.38M shares 10-Q · filed 2021-07-28 | 94.54M shares derived: average of 3 quarters · filed 2022-03-31 | 94.08M shares derived: average of 4 quarters · filed 2022-03-31 | |||
| 2021-03-31 | 94.23M shares 10-Q · filed 2021-05-17 | 93.55M shares derived: average of 2 quarters · filed 2022-03-31 | 93.27M shares derived: average of 3 quarters · filed 2022-03-31 | 93.13M shares derived: average of 4 quarters · filed 2022-03-31 | |||
| 2020-12-31 | 92.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 92.79M shares derived: average of 2 quarters · filed 2022-03-31 | 92.76M shares derived: average of 3 quarters · filed 2022-03-31 | 92.66M shares 10-K · filed 2022-03-31 | |||
| 2020-09-30 | 92.71M shares 10-Q · filed 2021-11-15 | 93.77M shares 10-Q · filed 2020-11-09 | 92.71M shares derived: average of 2 quarters · filed 2021-11-15 | 92.59M shares 10-Q · filed 2021-11-15 | 93.20M shares 10-Q · filed 2020-11-09 | 83.13M shares derived: average of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | 92.70M shares 10-Q · filed 2021-07-28 | 93.18M shares 10-Q · filed 2020-08-10 | 92.53M shares 10-Q · filed 2021-07-28 | 92.91M shares 10-Q · filed 2020-08-10 | 79.93M shares derived: average of 3 quarters · filed 2021-07-28 | 72.38M shares derived: average of 4 quarters · filed 2021-07-28 | |
| 2020-03-31 | 92.36M shares 10-Q · filed 2021-05-17 | 92.64M shares 10-Q · filed 2020-05-06 | 73.54M shares derived: average of 2 quarters · filed 2021-05-17 | 65.60M shares derived: average of 3 quarters · filed 2021-05-17 | 61.44M shares derived: average of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | 54.72M shares 10-K · filed 2020-03-16 | 52.22M shares derived: average of 2 quarters · filed 2020-11-09 | 51.13M shares derived: average of 3 quarters · filed 2020-11-09 | 50.35M shares 10-K · filed 2021-03-24 | |||
| 2019-09-30 | 49.72M shares 10-Q · filed 2020-11-09 | 49.34M shares derived: average of 2 quarters · filed 2020-11-09 | 48.88M shares 10-Q · filed 2020-11-09 | 48.64M shares derived: average of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | 48.96M shares 10-Q · filed 2020-08-10 | 48.46M shares 10-Q · filed 2020-08-10 | 48.28M shares derived: average of 3 quarters · filed 2020-08-10 | 48.16M shares derived: average of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | 47.95M shares 10-Q · filed 2020-05-06 | 47.95M shares derived: average of 2 quarters · filed 2020-05-06 | 47.90M shares derived: average of 3 quarters · filed 2020-05-06 | 47.75M shares derived: average of 4 quarters · filed 2020-05-06 | |||
| 2018-12-31 | 47.94M shares 10-K · filed 2020-03-16 | 47.87M shares derived: average of 2 quarters · filed 2020-03-16 | 47.68M shares derived: average of 3 quarters · filed 2020-03-16 | 47.53M shares 10-K · filed 2020-03-16 | |||
| 2018-09-30 | 47.79M shares 10-K · filed 2020-03-16 | 47.55M shares derived: average of 2 quarters · filed 2020-03-16 | 47.39M shares 10-Q · filed 2019-11-12 | 46.94M shares derived: average of 4 quarters · filed 2020-03-16 | |||
| 2018-06-30 | 47.30M shares 10-K · filed 2020-03-16 | 47.18M shares 10-Q · filed 2019-08-09 | 46.65M shares derived: average of 3 quarters · filed 2020-03-16 | 45.09M shares derived: average of 4 quarters · filed 2020-03-16 | |||
| 2018-03-31 | 47.06M shares 10-K · filed 2020-03-16 | 46.33M shares derived: average of 2 quarters · filed 2020-03-16 | 44.35M shares derived: average of 3 quarters · filed 2020-03-16 | 43.33M shares derived: average of 4 quarters · filed 2020-03-16 | |||
| 2017-12-31 | 45.60M shares 10-K · filed 2019-03-18 | 42.99M shares derived: average of 2 quarters · filed 2019-03-18 | 42.08M shares derived: average of 3 quarters · filed 2019-03-18 | 41.64M shares 10-K · filed 2020-03-16 | |||
| 2017-09-30 | 40.38M shares 10-K · filed 2019-03-18 | 40.32M shares derived: average of 2 quarters · filed 2019-03-18 | 40.30M shares 10-Q · filed 2018-11-09 | 39.70M shares derived: average of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | 40.27M shares 10-K · filed 2019-03-18 | 40.26M shares 10-Q · filed 2018-08-09 | 39.48M shares derived: average of 3 quarters · filed 2019-03-18 | 37.93M shares derived: average of 4 quarters · filed 2019-03-18 | |||
| 2017-03-31 | 40.25M shares 10-K · filed 2019-03-18 | 39.08M shares derived: average of 2 quarters · filed 2019-03-18 | 37.15M shares derived: average of 3 quarters · filed 2019-03-18 | 36.06M shares derived: average of 4 quarters · filed 2019-03-18 | |||
| 2016-12-31 | 37.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 35.60M shares derived: average of 2 quarters · filed 2019-03-18 | 34.66M shares derived: average of 3 quarters · filed 2019-03-18 | 34.18M shares 10-K · filed 2019-03-18 | |||
| 2016-09-30 | 33.27M shares 10-Q · filed 2017-11-14 | 33.03M shares derived: average of 2 quarters · filed 2017-11-14 | 32.94M shares 10-Q · filed 2017-11-14 | 32.90M shares derived: average of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | 32.78M shares 10-Q · filed 2017-08-14 | 32.76M shares 10-Q · filed 2017-08-14 | 32.77M shares derived: average of 3 quarters · filed 2017-08-14 | 32.53M shares derived: average of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | 32.74M shares 10-Q · filed 2017-05-15 | 32.77M shares derived: average of 2 quarters · filed 2017-05-15 | 32.44M shares derived: average of 3 quarters · filed 2017-05-15 | 30.75M shares derived: average of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | 32.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 32.29M shares derived: average of 2 quarters · filed 2017-03-30 | 30.09M shares derived: average of 3 quarters · filed 2017-03-30 | 27.60M shares 10-K · filed 2017-03-30 | |||
| 2015-09-30 | 31.79M shares 10-Q · filed 2016-11-14 | 28.74M shares derived: average of 2 quarters · filed 2016-11-14 | 25.87M shares 10-Q · filed 2016-11-14 | 20.92M shares derived: average of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | 25.70M shares 10-Q · filed 2016-08-15 | 22.86M shares 10-Q · filed 2016-08-15 | 17.29M shares derived: average of 3 quarters · filed 2016-08-15 | 13.10M shares derived: average of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | 19.98M shares 10-Q · filed 2016-05-16 | 13.09M shares derived: average of 2 quarters · filed 2016-05-16 | 8.90M shares derived: average of 3 quarters · filed 2016-05-16 | 6.81M shares derived: average of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | 6.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 3.37M shares derived: average of 2 quarters · filed 2016-03-30 | 2.42M shares derived: average of 3 quarters · filed 2016-03-30 | 1.94M shares 10-K · filed 2016-03-30 | |||
| 2014-09-30 | 532.26K shares 10-Q · filed 2015-11-16 | 528.04K shares derived: average of 2 quarters · filed 2015-11-16 | 524.60K shares 10-Q · filed 2015-11-16 | ||||
| 2014-06-30 | 523.83K shares 10-Q · filed 2015-08-14 | 520.70K shares 10-Q · filed 2015-08-14 | |||||
| 2014-03-31 | 517.54K shares 10-Q · filed 2015-05-14 | ||||||
| 2012-12-31 | 24.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | 24.24M shares derived: average of 2 quarters · filed 2013-03-20 | 24.21M shares derived: average of 3 quarters · filed 2013-03-20 | 24.18M shares 10-K · filed 2013-03-20 | |||
| 2012-09-30 | 24.17M shares 10-Q · filed 2012-11-14 | 24.17M shares derived: average of 2 quarters · filed 2012-11-14 | 24.14M shares 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | 24.16M shares 10-Q · filed 2012-08-14 | 24.12M shares 10-Q · filed 2012-08-14 | |||||
| 2011-12-31 | 21.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | 20.65M shares derived: average of 2 quarters · filed 2013-03-20 | 20.23M shares derived: average of 3 quarters · filed 2013-03-20 | 19.98M shares 10-K · filed 2013-03-20 | |||
| 2011-09-30 | 19.50M shares 10-Q · filed 2012-11-14 | 19.45M shares derived: average of 2 quarters · filed 2012-11-14 | 19.38M shares 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | 19.39M shares 10-Q · filed 2012-08-14 | 19.32M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |